Skip to content
10-Q

Quarterly Report

Ovid Therapeutics Inc. OVID

0001628280-25-024913

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 71.11M sh
Capex Q1 2025 · Mar 31, 2025 $0
Capex Q1 2025 · Mar 31, 2024 $19K
Cash And Equivalents Q1 2025 · Mar 31, 2025 $21.14M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $26.3M
Current Liabilities Q1 2025 · Mar 31, 2025 $9.31M
Current Liabilities Q1 2025 · Dec 31, 2024 $10.52M
Total Liabilities Q1 2025 · Mar 31, 2025 $22.38M
Total Liabilities Q1 2025 · Dec 31, 2024 $23.94M
Current Assets Q1 2025 · Mar 31, 2025 $45.92M
Current Assets Q1 2025 · Dec 31, 2024 $55.94M
Total Assets Q1 2025 · Mar 31, 2025 $81.65M
Total Assets Q1 2025 · Dec 31, 2024 $92.17M
Revenue Q1 2025 · Mar 31, 2025 $223.6M
Revenue Q1 2025 · Mar 31, 2024 $148K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$16.69M
Stockholders Equity Q1 2025 · Mar 31, 2024 $78.28M
Stockholders Equity Q1 2025 · Dec 31, 2023 $87.8M
Rd Expense Q1 2025 · Mar 31, 2024 $10.4M
Net Income Q1 2025 · Mar 31, 2024 −$11.69M
Operating Income Q1 2025 · Mar 31, 2024 −$17.42M